Log In
Print
BCIQ
Print
Print this Print this
 

AZD0424

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionTyrosine kinase inhibitor
Molecular Target Src
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today